Coaching Scorecards

Back to Scorecards

Sarah Chen

Sales Rep

Interaction INT-001 · Mar 8, 2026

Overall Score

82/100
Score Overview
Opening & RapportProduct KnowledgeNeeds AssessmentObjection HandlingCompliance & RegulatoryClosing & Next StepsEmpathy & Communication

Rubric Breakdown

Opening & Rapport

5/5

Observation

Sarah opened with a warm, professional greeting that acknowledged the physician's busy schedule. She set a clear agenda reference without being pushy.

Suggestion

Consider adding a brief recap of the previous interaction to strengthen continuity.

Evidence

[00:00]“Good morning, Dr. Walsh. Thank you for taking the time today. I know your schedu...”

Product Knowledge

4/5

Observation

Demonstrated strong knowledge of Veloratine's clinical data, including trial specifics and safety profile. Accurately cited efficacy endpoints.

Suggestion

Could strengthen by integrating real-world evidence and competitive differentiation to complement the clinical trial data.

Evidence

[01:45]“The VELOCITY trial showed a 32% reduction in systolic blood pressure compared to...”

Needs Assessment

4/5

Observation

Asked an insightful question about the physician's current patient challenges before presenting product information.

Suggestion

Could probe deeper into specific patient cases or ask about treatment goals to further tailor the discussion.

Evidence

[00:32]“Before I share that, I wanted to understand how things have been going with your...”

Objection Handling

4/5

Observation

Effectively addressed the renal safety concern with specific data and appropriate caveats.

Suggestion

When addressing the cost objection, could have explored the patient's specific insurance situation rather than providing general savings information.

Evidence

[02:40]“In the VELOCITY trial, the incidence of renal adverse events was 3.2% versus 2.8...”

Compliance & Regulatory

5/5

Observation

Proactively provided fair balance by disclosing contraindications and monitoring requirements without prompting.

Suggestion

Continue this strong practice of voluntary fair balance disclosure.

Evidence

[02:40]“Veloratine is contraindicated in patients with eGFR below 30, and regular renal ...”

Closing & Next Steps

4/5

Observation

Secured concrete next steps including sending materials and scheduling a follow-up visit.

Suggestion

Could summarize the key points discussed before transitioning to close to reinforce the value message.

Evidence

[05:00]“Absolutely, I'll send those over right after our call. Would it also be helpful ...”

Empathy & Communication

4/5

Observation

Maintained a professional and respectful tone throughout. Adapted communication style to the physician's level of clinical sophistication.

Suggestion

Could show more empathy toward the physician's frustration with treatment-resistant patients before pivoting to the solution.

Evidence

[01:30]“That's exactly the patient population where Veloratine has shown the most promis...”
Coaching Focus Areas
1
Competitive Differentiation

Develop stronger competitive messaging that positions Veloratine against other fourth-line hypertension agents.

Target: Proactively incorporate head-to-head or indirect comparison data when discussing Veloratine's place in therapy.

2
Real-World Evidence Integration

Supplement clinical trial data with real-world evidence and post-marketing outcomes to build broader credibility.

Target: Reference at least one real-world study or outcomes dataset when presenting efficacy data.